Nautilus Biotechnology Market Sentiment

Market sentiment signals for Nautilus Biotechnology (NAUT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 6.5% short float

Options Flow▲ 0.01 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

5 analysts

Options Flow (P/C)

0.01

More calls — Bullish

990 calls · 7 puts

Avg Consensus PT

+99.4%

Highest Price Target

+145.4%

Guggenheim

Lowest Price Target

+7.4%

Goldman Sachs

Short Interest

6.5%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 29, 2026	Roth Capital	Max Masucci—	+114.7%	$4	Initiate	Buy
Sep 9, 2026	Leerink Partners	Puneet Souda—	+145.4%	$4	Initiate	Outperform
Feb 27, 2026	Guggenheim	Subbu Nambi—	+145.4%	$3 → $4	Maintained	Buy
Dec 5, 2024	Goldman Sachs	Matthew Sykes—	+7.4%	$2 → $2	Downgrade	Neutral→Sell
Jun 27, 2024	Guggenheim	Subbu Nambi—	+268.1%	$6	Initiate	Buy
Jun 3, 2024	Jefferies	Tycho Peterson—	+84.0%	$5 → $3	Assumes	Buy→Hold